Suven Life Sciences informs about disclosure

02 Feb 2023 Evaluate
Suven Life Sciences has informed that it enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 31st December, 2022.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

147.45 -2.50 (-1.67%)
26-Feb-2026 11:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.20
Dr. Reddys Lab 1310.70
Cipla 1349.40
Zydus Lifesciences 932.60
Lupin 2314.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×